Stenocare A/S STENO.CO · DKK

Its shares trade on Nasdaq Copenhagen under the ticker STENO.CO. It has been listed since 26 October 2018. In the fiscal year to 31 December 2025, it reported revenue of DKK 7.0m and a net loss of DKK 2.4m. At that date it held total assets of DKK 12.6m and shareholders' equity of DKK 9.5m.

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

Figures and description from our data supplier, not checked against the company's own report.

• Ms. Marianne WierChairman of the Board
• Mr. Thomas Skovlund SchnegelsbergChief Executive Officer, Co-Founder
• Mr. Soeren KjaerCo-Founder, Chief Operating Officer
• Mr. Peter Bugge JohansenChief Financial Officer
• Mr. Rolf Steno PetersenCCO, Director, since 2017
• Mr. Soeren Melsing FrederiksenDirector
• Mr. Henrik PedersenDirector
• Mr. Jeppe PetersenIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.